« Previous
Next »
American Journal of Cardiology
Volume 105, Issue 2
, Pages 255-260
, 15 January 2010
Adherence to Guideline-Recommended Adjunctive Heart Failure Therapies Among Outpatient Cardiology Practices (Findings from IMPROVE HF)
References
- . HFSA 2006 comprehensive heart failure practice guideline. J Card Fail. 2006;12(suppl):e1–e122
- . Treatment of hypertension on the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association council for high blood pressure research and the councils on clinical cardiology and epidemiology and prevention. Circulation. 2007;115:2761–2788
- . ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112(suppl):e154–e235
- . 2009 Focused update incorporated into the ACC/AHA 2005 guideline for the diagnosis and management of chronic heart failure in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119(suppl):e391–e479
- . Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE registry. Arch Intern Med. 2005;165:1469–1477
- . Quality of care and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry. J Am Coll Cardiol. 2008;51:1675–1684
- . Characteristics and outcomes in African American patients with decompensated heart failure. Arch Intern Med. 2008;168:1152–1158
- . Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Am Heart J. 2009;157:754–762
- . Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Circ Heart Fail. 2008;1:98–106
- . NHS heart failure survey: a survey of acute heart failure admissions in England, Wales and Northern Ireland. Heart. 2008;94:172–177
- . Risk-treatment mismatch in the pharmacotherapy of heart failure. JAMA. 2005;294:1240–1247
- . Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry. Am Heart J. 2007;154:12–38
- . Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med. 2004;351:2049–2057
- . Strategies to improve the use of evidence-based heart failure therapies: OPTIMIZE-HF. Rev Cardiovasc Med. 2004;5(suppl 1):S45–S54
- . Race-based therapeutics. Curr Hypertens Rep. 2008;10:276–285
- . Hypertension treatment and the prevention of coronary heart disease in the elderly. Am Fam Phys. 1999;59:1248–1256http://www.aafp.org/afp/990301ap/1248.htmlAccessed: March 10, 2009
- . The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)). JAMA. 2002;288:2981–2997
- . Randomized clinical outcome trials of statins in heart failure. Heart Fail Clin. 2008;4:225–229
- . Rosuvastatin in older patients with systolic heart failure. N Engl J Med. 2007;357:2248–2261
- . Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372:1231–1239
- . Aspirin use in chronic heart failure: what should we recommend to the practitioner?. J Am Coll Cardiol. 2005;46:963–966
- . Is aspirin safe for patients with heart failure?. Br Heart J. 1995;74:215–219
- . Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J (Clin Res Ed). 1988;296:320–331
- . Collaborative overview of randomised trials of antiplatelet therapy—I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J. 1994;308:81–106
The IMPROVE HF registry and this study are sponsored by Medtronic, Inc., Minneapolis, Minnesota.
PII: S0002-9149(09)02335-2
doi: 10.1016/j.amjcard.2009.08.681
© 2010 Elsevier Inc. All rights reserved.
« Previous
Next »
American Journal of Cardiology
Volume 105, Issue 2
, Pages 255-260
, 15 January 2010
